PubMed · 2007 · 37 citations · 24 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCancer MetabolismMetabolic ReprogrammingMetabolic Reprogramming In CancerOncology NutritionAnimal Disease ModelsDietary Purine RestrictionMethionine MetabolismNutrition During ChemotherapyOncology Diet TherapySensitizationTherapeutic Index DeterminationTherapeutic Index Management
BACKGROUND: Methionine (MET) depletion used in association with chemotherapy improves the therapeutic index in animal models. This potentiating effect may be due to tumor cell sensitization to chloroethylnitrosoureas through their MET dependency and the down-regulation of O6- methylguanine-DNA methyltransferase (MGMT). Our purpose was to evaluate the impact of the association of a dietary MET restriction with nitrosourea treatment on MGMT activity in peripheral blood mononuclear cells (PBMCs). PATIENTS AND METHODS: Six patients with metastatic cancer (melanoma and glioma) received 4 cycles of a MET-free diet with cystemustine (60 mg/m2). RESULTS: MGMT activity in PBMCs decreased by an average of 13% from 553+/-90 fnol/mg before the diet to 413+/-59 fmol/mg after the diet + chemotherapy period (p=0.029). The decrease of MGMT activity was not affected by the duration of the MET-free diet period but seems to be correlated to the plasma MET depletion induced by the MET-free diet.
24
Kurt A. Jaeckle, Harmon J. Eyre, Jeannette J. Townsend et al. · Journal of Clinical Oncology · 1998 · 297 citations
C Jacquillat, D. Khayat, Pierre Banzet et al. · Cancer · 1990 · 241 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +12
J Costello, Bernard W. Futscher, Keizo Tano et al. · Journal of Biological Chemistry · 1994 · 201 citations · Full text